Literature DB >> 10414943

Reversal of multidrug resistance in hematological malignancies.

P J Vossebeld1, P Sonneveld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10414943     DOI: 10.1016/s0268-960x(99)90013-9

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


× No keyword cloud information.
  2 in total

1.  Biology and modulation of multidrug resistance (MDR) in hematological malignancies.

Authors:  Masao Hirose
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 2.  Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease.

Authors:  Chikashi Yoshida; Junia V Melo
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.